P-glycoprotein, breast cancer resistance protein, organic anion transporter 3, and transporting peptide 1a4 during blood-brain barrier maturation: Involvement of Wnt/β-catenin and endothelin-1 signaling

Molecular Pharmaceutics

Volumn 10, Issue 5, 2013, Pages 1566-1580

  Harati, Rania ^a   Benech, Henri ^a   Villégier, Anne Sophie ^b   Mabondzo, Aloïse ^a  

^a Institut National de la Recherche Agronomique   (France)

^b INSTITUT NATIONAL DE L ENVIRONNEMENT INDUSTRIEL ET DES RISQUES INERIS   (France)

Author keywords

catenin and endothelin 1 signaling; bcrp; oat3 and oatp1a4 transporters; ontogenesis of blood brain barrier; P gp; preterm and adulthood blood brain barrier

Indexed keywords

BETA CATENIN; BREAST CANCER RESISTANCE PROTEIN; CARRIER PROTEINS AND BINDING PROTEINS; ENDOTHELIN 1; MESSENGER RNA; MULTIDRUG RESISTANCE PROTEIN; ORGANIC ANION TRANSPORTER 3; TRANSPORTING PEPTIDE 1A4; UNCLASSIFIED DRUG; WNT PROTEIN; ABC TRANSPORTER; ABCG2 PROTEIN, RAT; ENDOTHELIN A RECEPTOR ANTAGONIST; GLYCOGEN SYNTHASE KINASE 3; ORGANIC ANION TRANSPORTER; SLCO1A4 PROTEIN, RAT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; ASTROCYTE; BLOOD BRAIN BARRIER; BRAIN CAPILLARY; BRAIN CELL; BRAIN MATURATION; CONTROLLED STUDY; DOWN REGULATION; ENDOTHELIUM CELL; GENE EXPRESSION; IN VITRO STUDY; IN VIVO STUDY; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; RAT; REGULATORY MECHANISM; SIGNAL TRANSDUCTION; ANIMAL; ANTAGONISTS AND INHIBITORS; BIOLOGICAL MODEL; DRUG EFFECTS; GENE EXPRESSION REGULATION; GENETICS; GROWTH, DEVELOPMENT AND AGING; HUMAN; METABOLISM; WISTAR RAT; WNT SIGNALING PATHWAY;

ANIMALS; ATP-BINDING CASSETTE TRANSPORTERS; BETA CATENIN; BLOOD-BRAIN BARRIER; ENDOTHELIN A RECEPTOR ANTAGONISTS; ENDOTHELIN-1; GENE EXPRESSION REGULATION, DEVELOPMENTAL; GLYCOGEN SYNTHASE KINASE 3; HUMANS; MALE; MODELS, NEUROLOGICAL; ORGANIC ANION TRANSPORTERS; ORGANIC ANION TRANSPORTERS, SODIUM-INDEPENDENT; P-GLYCOPROTEIN; RATS; RATS, WISTAR; RNA, MESSENGER; SIGNAL TRANSDUCTION; WNT SIGNALING PATHWAY;

EID: 84877252893     PISSN: 15438384     EISSN: 15438392     Source Type: Journal    
DOI: 10.1021/mp300334r     Document Type: Article

References (34)

1. Loscher, W.; Potschka, H. Drug resistance in brain diseases and the role of drug efflux transporters Nat. Rev. Neurosci. 2005, 6, 591-602
2. Hagenbuch, B.; Meier, P. J. Organic anion transporting polypeptides of the OATP/ SLC21 family: phylogenetic classification as OATP/ SLCO superfamily, new nomenclature and molecular/functional properties Pflugers Arch. 2004, 447, 653-665
3. Engelhardt, B. Development of the blood-brain barrier Cell Tissue Res. 2003, 314, 119-129
4. Kooij, G.; Mizee, M. R.; Van Horssen, J.; Reijerkerk, A.; Witte, M. E.; Drexhage, J. A.; van der Pol, S. M.; van Het Hof, B.; Scheffer, G.; Scheper, R.; Dijkstra, C. D.; van der Valk, P.; de Vries, H. E. Adenosine triphosphate-binding cassette transporters mediate chemokine (C-C motif) ligand 2 secretion from reactive astrocytes: relevance to multiple sclerosis pathogenesis Brain 2011, 134, 555-570
5. Jorajuria, S.; Dereuddre-Bosquet, N.; Becher, F.; Martin, S.; Porcheray, F.; Garrigues, A.; Mabondzo, A.; Benech, H.; Grassi, J.; Orlowski, S.; Dormont, D.; Clayette, P. ATP binding cassette multidrug transporters limit the anti-HIV activity of zidovudine and indinavir in infected human macrophages Antivir. Ther. 2004, 9, 519-528
6. Bousquet, L.; Pruvost, A.; Guyot, A. C.; Farinotti, R.; Mabondzo, A. Combination of tenofovir and emtricitabine plus efavirenz: in vitro modulation of ABC transporter and intracellular drug accumulation Antimicrob. Agents Chemother. 2009, 53, 896-902
7. Jones, H. C.; Keep, R. F.; Butt, A. M. The development of ion regulation at the blood-brain barrier Prog. Brain Res. 1992, 91, 123-131
8. Daood, M.; Tsai, C.; Ahdab-Barmada, M.; Watchko, J. F. ABC transporter (P-gp/ABCB1, MRP1/ABCC1, BCRP/ABCG2) expression in the developing human CNS Neuropediatrics 2008, 39, 211-218
9. EK, J. C.; Wong, A.; Liddelow, S. A.; Johansson, P. A.; Dziegielewska, K. M.; Saunders, N. R. Efflux mechanisms at the developing brain barriers: ABC-transporters in the fetal and postnatal rat Toxicol. Lett. 2010, 197, 51-59
10. Liebner, S.; Corada, M.; Bangsow, T.; Babbage, J.; Taddei, A.; Czupalla, C. J.; Reis, M.; Felici, A.; Wolburg, H.; Fruttiger, M.; Taketo, M. M.; von Melchner, H.; Plate, K. H.; Gerhardt, H.; Dejana, E. Wnt/beta-catenin signaling controls development of the blood-brain barrier J. Cell Biol. 2008, 183, 409-417
11. Logan, C. Y.; Nusse, R. The Wnt signaling pathway in development and disease Annu. Rev. Cell. Dev. Biol. 2004, 20, 781-810
12. Lim, J. C.; Kania, K. D.; Wijesuriya, H.; Chawla, S.; Sethi, J. K.; Pulaski, L.; Romero, I. A.; Couraud, P. O.; Weksler, B. B.; Hladky, S. B.; Barrand, M. A. Activation of beta-catenin signalling by GSK-3 inhibition increases p-glycoprotein expression in brain endothelial cells J. Neurochem. 2008, 106, 1855-1865
13. Liu, X.; Smith, B. J.; Chen, C.; Callegari, E.; Becker, S. L.; Chen, X.; Cianfrogna, J.; Doran, A. C.; Doran, S. D.; Gibbs, J. P.; Hosea, N.; Liu, J.; Nelson, F. R.; Szewc, M. A.; Van Deusen, J. Use of a physiologically based pharmacokinetic model to study the time to reach brain equilibrium: an experimental analysis of the role of blood-brain barrier permeability, plasma protein binding, and brain tissue binding J. Pharmacol. Exp. Ther. 2005, 313, 1254-1262
14. Hammarlund-Udenaes, M.; Friden, M.; Syvanen, S.; Gupta, A. On the rate and extent of drug delivery to the brain Pharm. Res. 2008, 25, 1737-1750
15. Wright, C. E.; Fozard, J. R. Regional vasodilation is a prominent feature of the haemodynamic response to endothelin in anaesthetized, spontaneously hypertensive rats Eur. J. Pharmacol. 1998, 155, 201-203
16. Yanagisawa, M.; Kurihara, H.; Kimura, S.; Tomobe, Y.; Kobayashi, M.; Mitsui, Y.; Yazaki, Y.; Goto, K.; Masaki, T. A novel potent vasoconstrictor peptide produced by vascular endothelial cells Nature 1988, 332, 411-415
17. Bauer, B.; Hartz, A. M.; Miller, D. S. Tumor necrosis factor alpha and endothelin-1 increase P-glycoprotein expression and transport activity at the blood-brain barrier Mol. Pharmacol. 2007, 71, 667-675
18. Hawkins, B. T.; Rigor, R.; Miller, D. S. Rapid loss of blood-brain barrier P-glycoprotein activity through transporter internalization demonstrated using a novel in situ proteolysis protection assay J. Cereb. Blood Flow. Metab. 2010, 30, 1593-1597
19. Hembury, A.; Mabondzo, A. Endothelin-1 reduces p-glycoprotein transport activity in an in vitro model of human adult blood-brain barrier Cell Mol. Neurobiol. 2008, 28, 915-921
20. Chesire, D. R.; Isaacs, W. B. Ligand-dependent inhibition of beta-catenin/TCF signaling by androgen receptor Oncogene 2002, 21, 8453-869
21. Mulholland, D. J.; Read, J. T.; Rennie, P. S.; Cox, M. E.; Nelson, C. C. Functional localization and competition between the androgen receptor and T-cell factor for nuclear beta-catenin: a means for inhibition of the Tcf signaling axis Oncogene 2003, 22, 5602-5613
22. Kniesel, U.; Risau, W.; Wolburg, H. Development of blood-brain barrier tight junctions in the rat cortex Brain Res. Dev. Brain Res. 1996, 96, 229-40
23. Lacombe, O.; Videau, O.; Chevillon, D.; Guyot, A. C.; Contreras, C.; Blondel, S.; Nicolas, L.; Ghettas, A.; Bénech, H.; Thevenot, E.; Pruvost, A.; Bolze, S.; Krzaczkowski, L.; Prévost, C.; Mabondzo, A. In vitro primary human and animal cell-based blood-brain barrier models as a screening tool in drug discovery Mol. Pharmaceutics 2011, 8, 651-663
24. Mabondzo, A.; Bottlaender, M.; Guyot, A. C.; Tsaouin, K.; Deverre, J. R.; Balimane, P. V. Validation of In Vitro Cell-Based Human Blood-Brain Barrier Model Using Clinical Positron Emission Tomography Radioligands to Predict In Vivo Human Brain Penetration Mol. Pharmaceutics 2010, 7, 1805-1815
25. Litman, T.; Brangi, M.; Hudson, E.; Fetsch, P.; Abati, A.; Ross, D. D.; Miyake, K.; Resau, J. H.; Bates, S. E. The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2) J. Cell Sci. 2000, 113, 2011-21
26. Cavet, M. E.; West, M.; Simmons, N. L. Transport and epithelial secretion of the cardiac glycoside, digoxin, by human intestinal epithelial (Caco-2) cells Br. J. Pharmacol. 1996, 118, 1389-1396
27. Kusuhara, H.; Sekine, T.; Utsunomiya-Tate, N.; Tsuda, M.; Kojima, R.; Cha, S. H.; Sugiyama, Y.; Kanai, Y.; Endou, H. Molecular cloning and characterization of a new multispecific organic anion transporter from rat brain J. Biol. Chem. 1999, 274, 13675-13680
28. Ose, A.; Kusuhara, H.; Endo, C.; Tohyama, K.; Miyajima, M.; Kitamura, S.; Sugiyama, Y. Functional characterization of mouse organic anion transporting peptide 1a4 in the uptake and efflux of drugs across the blood-brain barrier Drug Metab. Dispos. 2010, 38, 168-176
29. Takashima, T.; Yokoyama, C.; Mizuma, H.; Yamanaka, H.; Wada, Y.; Onoe, K.; Nagata, H.; Tazawa, S.; Doi, H.; Takahashi, K.; Morita, M.; Kanai, M.; Shibasaki, H.; Kusuhara, Y.; Sugiyama, Onoe, Y.; Watanabe, Y. Developmental changes in P-glycoprotein function in the blood-brain barrier of nonhuman primates: PET study with R-11C-verapamil and 11C-oseltamivir J. Nucl. Med. 2011, 52, 950-957
30. Dauchy, S.; Dutheil, F.; Weaver, R. J.; Chassoux, F.; Daumas-Duport, C.; Couraud, P. O.; Scherrmann, J. M.; De Waziers, I.; Declèves, X. ABC transporters, cytochromes P450 and their main transcription factors: expression at the human blood-brain barrier J. Neurochem. 2008, 107, 1518-1528
31. Asaba, H.; Hosoya, K.; Takanaga, H.; Ohtsuki, S.; Tamura, E.; Takizawa, T.; Terasaki, T. Blood-brain barrier is involved in the efflux transport of a neuroactive steroid, dehydroepiandrosterone sulfate, via organic anion transporting polypeptide 2 J. Neurochem. 2000, 75, 1907-16
32. Sugiyama, D.; Kusuhara, H.; Shitara, Y.; Abe, T.; Meier, P. J.; Sekine, T.; Endou, H.; Suzuki, H.; Sugiyama, Y. Characterization of the efflux transport of 17beta-estradiol-D-17beta-glucuronide from the brain across the blood-brain barrier J. Pharmacol. Exp. Ther. 2001, 298, 316-22
33. Kikuchi, R.; Kusuhara, H.; Abe, T.; Endo, H.; Sugiyama, Y. Involvement of multiple transporters in the efflux of 3-hydroxy-3-methylglutaryl-CoA reductase inhibitors across the blood-brain barrier J. Pharmacol. Exp. Ther. 2004, 311, 1147-53
34. Daneman, R.; Agalliu, D.; Zhou, Kuhnert, F.; Kuo, C. J.; Barres, B. A. Wnt/beta-catenin signaling is required for CNS, but not non-CNS, angiogenesis Proc. Natl. Acad. Sci. U.S.A. 2009, 106, 641-646